Výsledky vyhledávání - "Rutger van den Bor"

Estimation and expected sample size in Simon's two-stage designs that stop as early as possible

Autor: Antonios Daletzakis, Rutger van den Bor, Marianne A. Jonker, Kit C. B. Roes, Harm van Tinteren

Publikováno v: Pharmaceutical Statistics, 21, 5, pp. 879-894
Pharmaceutical Statistics, 21, 879-894

Contains fulltext : 283283.pdf (Publisher’s version ) (Closed access) In early phase clinical studies in oncology, Simon's two-stage designs are widely used. The trial design could be made more efficient by stopping early in the second stage when t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ad47867e45712c1a587f584e651b03
https://hdl.handle.net/2066/283283

Zobrazit plný text záznamu

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators

Autor: Danya Muilwijk, Marlou Bierlaagh, Peter van Mourik, Jasmijn Kraaijkamp, Renske van der Meer, Rutger van den Bor, Harry Heijerman, René Eijkemans, Jeffrey Beekman, Kors van der Ent

Publikováno v: Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1376
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 1376, p 1376 (2021)

The clinical response to cystic fibrosis transmembrane conductance regulator (CFTR) modulators is variable within people with cystic fibrosis (pwCF) homozygous for the F508del mutation. The prediction of clinical effect in individual patients would b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51272d6a1de871846dda421951b34def

Zobrazit plný text záznamu

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Autor: Pieter R. Stella, Leo Timmers, Stefan Koudstaal, Mera Stein, Geert E. Leenders, Michiel Voskuil, Rik Rozemeijer, Peter Frambach, Bruno Pereira, Rutger van den Bor, Adriaan O. Kraaijeveld, Kit C.B. Roes, Pieter A. Doevendans, Saskia Z. Rittersma, Pierfrancesco Agostoni

Publikováno v: Circulation. 139:67-77

Background: Polymer-free amphilimus-eluting stents (PF-AES) represent a novel elution technology in the current era of drug-eluting stents. The clinical safety and efficacy of PF-AES as compared with latest-generation permanent-polymer zotarolimus-el

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::749bca92f1c12cf3498d9b75f5cc1e5e
https://doi.org/10.1161/circulationaha.118.037707

Zobrazit plný text záznamu

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Autor: Rik, Rozemeijer, Mera, Stein, Michiel, Voskuil, Rutger, van den Bor, Peter, Frambach, Bruno, Pereira, Stefan, Koudstaal, Geert E, Leenders, Leo, Timmers, Saskia Z, Rittersma, Adriaan O, Kraaijeveld, Pierfrancesco, Agostoni, Kit C, Roes, Pieter A, Doevendans, Pieter R, Stella

Publikováno v: Circulation. 139(1)

Polymer-free amphilimus-eluting stents (PF-AES) represent a novel elution technology in the current era of drug-eluting stents. The clinical safety and efficacy of PF-AES as compared with latest-generation permanent-polymer zotarolimus-eluting stents

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c07cf0c4b92cf6ad4cee67542afd074b
https://pubmed.ncbi.nlm.nih.gov/30586704

Zobrazit plný text záznamu

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial

Autor: Melchior C Nierman, Frans H. Rutten, Wim F Buding, Huiberdina L. Koek, Nynke M Wiersma, Sander van Doorn, Martin E.W. Hemels, Menno V. Huisman, Rutger van den Bor, Kit C.B. Roes, Arno W. Hoes, Linda Joosten, Geert-Jan Geersing

Publikováno v: BMJ Open, 9(12). BMJ Publishing Group
BMJ Open

IntroductionClinical guidelines recommend non-vitamin K antagonist oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) for stroke prevention in most patients with atrial fibrillation (AF). Frail elderly were under-represented in the landmar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5867494e3d64c3d9063ff028c34e7d
https://doi.org/10.1136/bmjopen-2019-032488

Zobrazit plný text záznamu

Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis

Autor: Arjen Steijaert, Jeannette Ossewaarde-van Norel, Rutger van den Bor, Joke H. de Boer, Rebecca K. Stellato

Publikováno v: Ocular Immunology and Inflammation. 23:67-73

Purpose: To investigate the development of macular edema (ME) in relation to the duration of uveitis and visual outcome in uveitis associated with juvenile idiopathic arthritis (JIA).Methods: Sixty-one patients with JIA-uveitis (116 eyes) were invest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71fd03021042aabe721d00d1d030aaea
https://doi.org/10.3109/09273948.2013.871566

Zobrazit plný text záznamu

Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring

Autor: Diederick E. Grobbee, Rutger van den Bor, Veronica Walsh, Catherine Harvey, Elaine A. Irving, Rafael Alfonso-Cristancho, Nadia Garman, Paco M J Welsing

Publikováno v: Journal of Clinical Epidemiology, 91, 6. Elsevier USA

Pragmatic trials offer the opportunity to obtain real-life data on the relative effectiveness and safety of a treatment before or after market authorisation. This is the penultimate paper in a series of eight, describing the impact of design choices

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ce18b42174eebe682a93362df8a25c8
https://pubmed.ncbi.nlm.nih.gov/28502812

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání